Translate page

Collage FlaggenYou can view recordings of the 'iCMLf conversations on CML and COVID-19' in non-English languages here.
Additional conversations in Mandarin, Russian, Spanish and French will be made available over the next couple of weeks. The content of the presentations express the individual opinions of the respective experts.

  • Dr Katia Pagnano, Universidade de Campinas, São Paulo (Brazil)
  • Dr Ana Carolina Toreli, Hospital Brigadeiro, São Paulo (Brazil)
  • Dr Carla Boquimpani, Instituto Estadual de Hematologica Arthur de
    Sigueira Cavalcanti, Rio de Janeiro (Brazil)                                                                     
 

 

Flagge Brasilien

CML management during the COVID-19 pandemic – perspectives from Brazil
(in Portuguese)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Situação atual da COVID no Brasil
  • O que sabemos sobre LMC e COVID

  • Recomendações para o tratamento da LMC durante a pandemia:
    tratamento do paciente recém diagnosticado, pacientes em tratamento
    - necessidade de ajuste de dose/troca/interrupção,
    considerações sobre TFR durante a pandemia

  • Recomendações para o tratamento do paciente com LMC e COVID:
    no recém diagnosticado, necessidade de ajuste de dose/troca/interrupção
    durante a COVID, interações dos TKI com outras drogas
  • Perspectivas futuras: vacinas, tratamentos
  • Dr Jiang Qian, Peking University People’s Hospital, Beijing (China)
  • Dr Xuelin Dou, Peking University People’s Hospital, Beijing (China)

 

 

Flagge ChinaCML management during the COVID-19 pandemic
– perspectives from China (in Mandarin)

incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • Patients with hematological malignancies during the SARS-CoV-2 pandemic

  • Patients with chronic myeloid leukemia during the SARS-CoV-2 pandemic

  • CML treatment recommendations for patients without COVID-19 during the SARS-CoV-2 pandemic

 

 

 

 

 

 

 

 

 

  • Dr Elza Lomaia, Almazov National Medical Research Centre, St. Petersburg
    (Russian Federation)
  • Dr Jurii Osipov, Almazov National Medical Research Centre, St. Petersburg
    (Russian Federation)
  • Dr Ekaterina Chelysheva, National Research Centre for Hematology, Moscow
    (Russian Federation)
 

Coming soon:

Flagge RusslandCML management during the COVID-19 pandemic
– perspectives from Russia (in Russian)
incl. Q&A session

Watch the webinar to hear experience and perspectives on topics like;

  • CML treatment recommendations for patients without COVID-19
    including therapy initiation / therapy switch / monitoring / new trials and drugs for CML
  • The optimal strategy for prevention of COVID-19 and management
    of COVID-19 patients
  • Recommendations for treating patients with CML and COVID-19
    including therapy initiation / therapy switch / therapy stopping /
    any interaction with COVID-19 treatment / TFR
  • Summary